Floatz logo

Anti-Cea Car-T Cells

Liver Metastases

Roger Williams Medical CenterCell therapyPhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
73/ 100

Competitive context

36 Active assets in the Liver Metastases cohort.

Asset / SponsorPhaseRating
Eloxatin
Sun Yat-sen University
Phase 3BB
Irinotecan
Kamya Sankar
Phase 3BB
FLUOROURACILUM
Sun Yat-sen University
Phase 3BB
Calcium folinate pentahydrate
Fudan University
Phase 3BB
Ipilimumab
Vastra Gotaland Region
Phase 3B

View all 50 →

Same molecule, other indications

Anti-Cea Car-T Cells is also rated in:

malignant pancreatic neoplasmDormant
BB
Indicative ·
64 / 100
View asset →
liver cancerDormant
CC
Indicative ·
43 / 100
View asset →
CarcinomaDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →